Latest Articles

Publication Date
MP backs campaign to improve early bowel cancer diagnosis - The Argus

MP backs campaign to improve early bowel cancer diagnosis The Argus

Published: April 21, 2026, 4 a.m.
FDA Approves IMFINZI Plus Carboplatin and Paclitaxel for Certain Patients With Endometrial Cancer - EMJ

FDA Approves IMFINZI Plus Carboplatin and Paclitaxel for Certain Patients With Endometrial Cancer EMJ

Published: April 21, 2026, 3:59 a.m.
JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments | Newswise - Newswise

JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments | Newswise Newswise

Published: April 21, 2026, 1:10 a.m.
Empowering women's health with miRNA-integrated nanochemical approaches: from reproductive health to cancer care.

MicroRNAs (miRNAs), a category of small (18-25 nucleotides) non-coding transcripts that modulate gene expression at the post-transcriptional level, are necessary for regulatory processes in female reproduction, specifically in ovarian function …

Published: April 21, 2026, midnight
Circulating Tumor DNA in Ovarian Cancer: Emerging Roles in Early Detection, Risk Stratification, and Disease Monitoring.

Early diagnosis of ovarian cancer remains one of the most important unmet needs in gynecologic oncology because survival is strongly stage-dependent and most patients still present with disseminated disease. Conventional …

Published: April 21, 2026, midnight
GSK’s Phase I ADC trial succeeds in treating advanced gynecological cancers - BioXconomy

GSK’s Phase I ADC trial succeeds in treating advanced gynecological cancers BioXconomy

Published: April 20, 2026, 2:38 p.m.
JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments - Roswell Park Comprehensive Cancer Center

JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments Roswell Park Comprehensive Cancer Center

Published: April 20, 2026, 1 p.m.
High response rates in platinum-resistant ovarian cancer with immunotherapy agents - MSN

High response rates in platinum-resistant ovarian cancer with immunotherapy agents MSN

Published: April 20, 2026, 8:14 a.m.
Ascentage Pharma Presents Promising Cancer Research at AACR - The Clinical Trial Vanguard

Ascentage Pharma Presents Promising Cancer Research at AACR The Clinical Trial Vanguard

Published: April 20, 2026, 8 a.m.
'I'm a gynaecologist and there's hidden ovarian cancer symptom you must never ignore' - The Mirror

'I'm a gynaecologist and there's hidden ovarian cancer symptom you must never ignore' The Mirror

Published: April 19, 2026, 6 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!